Indeed, IGF1R blockade suppressed IGF1R signaling and YAP1 expression in a dose-dependent manner, suppressing tumor cell proliferation, self-renewal, and enhancing survival in orthotopic GBM and BC models (Fig. 5C, 5H–I). The gene discussed is YAP1; the disease is glioblastoma.